Climb Bio's total assets for Q4 2024 were $217.19M, a decrease of -2.26% from the previous quarter. CLYM total liabilities were $5.31M for the fiscal quarter, a 55.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.